Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination With Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

BioDrugs - United Kingdom
doi 10.1007/s40259-018-0322-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Systematic Review and Economic Evaluation of Bevacizumab and Cetuximab for the Treatment of Metastatic Colorectal Cancer

Health Technology Assessment
MedicineHealth Policy
2007English

Optimal Sequences and Combination of Chemotherapy and Monoclonal Antibodies in the Treatment of Patients With Metastatic Colorectal Cancer

Malignant tumours
2018English

Effect of Application and Intensity of Bevacizumab-Based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-Analysis

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Palliative Chemotherapy for Advanced Colorectal Cancer: Systematic Review and Meta-Analysis

Annales de Chirurgie
2003English

Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

Oncologist
Cancer ResearchMedicineOncology
2017English

Comparative Safety and Effectiveness of Serotonin Receptor Antagonists in Patients Undergoing Chemotherapy: A Systematic Review and Network Meta-Analysis

BMC Medicine
Medicine
2016English

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Anti-Egfr Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy